VivoSim Labs signs seven-figure deal with top 10 global pharmaceutical company
VIVS VivoSim Labs Inc
$0.29 +142.92%
View chart & analysis → - 1VivoSim Labs has signed a seven-figure contract with a top 10 global pharmaceutical company.
- 2VivoSim Labs expects to exceed its FY2027 revenue growth guideline by more than 500%.
- 3VivoSim Labs announced a collaboration with Kemveda Life Sciences on November 3.
So what's the key point?
VivoSim Labs signed a large contract with a global pharmaceutical company. Revenue for 2027 is expected to be more than 500% higher than projected.
Source InvestorsHub +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.